Biogen (BIIB) PT Lowered to $343 at Wells Fargo
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Biogen (BIIB) PT Lowered to $290 at Oppenheimer on CRL for MDD
August 7, 2023 6:28 AM EDTOppenheimer analyst Jay Olson lowered the price target on Biogen (NASDAQ: BIIB) to $290.00 (from $360.00) while maintaining a Outperform rating.
The analyst commented, "The MDD CRL for zuranolone deals BIIB a major blow but not a knockout. We expected BIIB to bolster topline growth... More



